Treatment Patterns and Clinical Outcomes Among Patients with Metastatic Non-small Cell Lung Cancer Without Actionable Genomic Alterations Previously Treated with Platinum-Based Chemotherapy and Immunotherapy

• Main Authors: Jerome H. Goldschmidt (Author), Wan-Yu Tseng (Author), Yunfei Wang (Author), Janet Espirito (Author), Anupama Vasudevan (Author), Michelle Silver (Author), Jackie Kwong (Author), Ruchit Shah (Author), Elizabeth Marrett (Author)
• Format: Book
• Published: Adis, Springer Healthcare, 2024-06-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Abstract Background For patients with metastatic non-small cell lung cancer, timely molecular testing is essential to determine the appropriate course of therapy. Initial treatment with platinum chemotherapy and/or an immune checkpoint inhibitor (ICI) is the standard of care for patients without act...